You are here

mirikizumab

Eli Lilly Was Hoping for 5 Big Drug Launches This Year. Here's How It Has Done Thus Far.

Motley Fool

Fri, 11/10/23 - 12:19 pm

Roche, Lilly or Pfizer: Who's the Winner in IBD Wars?

Motley Fool

Sun, 10/29/23 - 08:44 pm

ulcerative colitis

Crohn's Disease

Lilly’s ulcerative colitis therapy mirikizumab finally snags FDA approval

BioSpace

Fri, 10/27/23 - 11:54 am

ulcerative colitis

Lilly’s Mirikizumab Shows Long-Term Remission in Phase III Crohn’s Trial

BioSpace

Thu, 10/12/23 - 05:22 pm

Crohn's Disease

Eli Lilly receives UK approval for ulcerative colitis treatment

Biopharma Reporter

Mon, 09/25/23 - 10:13 am

ulcerative colitis

FDA declines to approve Eli Lilly's bowel disease drug

Yahoo/Reuters

Thu, 04/13/23 - 10:19 pm

JPM23: Amid launch spree, Eli Lilly expects revenue growth at the 'high end of the industry,' CFO says

Fierce Pharma

Thu, 01/12/23 - 10:27 am

Eli Lilly’s 2023 guidance: Up to 4 new drugs on the way

Medical Marketing and Media

Tue, 12/13/22 - 11:54 pm

Second trial opens door for Lilly’s mirikizumab in ulcerative colitis

Pharmaforum

Tue, 05/24/22 - 10:45 am

clinical trials

ulcerative colitis

Could This Be Eli Lilly's Next Blockbuster Drug?

Motley Fool

Sun, 03/20/22 - 11:01 pm

ulcerative colitis

Lilly unveils mirikizumab data in ulcerative colitis as it preps filings

Pharmaforum

Mon, 02/21/22 - 10:36 am

ulcerative colitis

clinical trials

Eli Lilly's mirikizumab improves fatigue in patients with Crohn's disease in Phase 2 trial

Seeking Alpha

Wed, 05/26/21 - 11:34 pm

clinical trials

Crohn’s disease

Crowded psoriasis market cuts Lilly’s mirikizumab ambitions

Pharmaforum

Wed, 04/28/21 - 10:24 am

Lilly scraps IL-23 psoriasis program despite phase 3 success, focuses on IBD race against AbbVie, J&J

Fierce Biotech

Tue, 04/27/21 - 10:50 am

Lilly's Skyrizi rival hits goal in ulcerative colitis phase 3, as it ups the ante against AbbVie

Fierce Biotech

Tue, 03/16/21 - 10:56 am

clinical trials

ulcerative colitis

Lilly shows more positive Crohn's data for its IL-23 inhibitor as it continues to chase down rivals

Endpoints

Mon, 10/12/20 - 10:28 am

Crohn's Disease

clinical trials

Eli Lilly’s Mirikizumab Hits the Mark in Phase III Study, Bests Cosentyx

BioSpace

Sat, 07/18/20 - 12:17 pm

clinical trials

Lilly spends big on mirikizumab

EP Vantage

Thu, 02/13/20 - 10:40 am

clinical trials

Lilly’s Mirikizumab succeeds in phase 2 study in Crohn’s disease

Pharmaceutical Business Review

Wed, 05/22/19 - 09:55 am

Crohn's Disease

Lilly's experimental colitis drug posts positive Phase 2 data

Biopharma Dive

Wed, 06/6/18 - 03:04 pm

ulcerative colitis

monoclonal antibodies